-
Oppenheimer: We Still Love OvaScience
Wednesday, April 8, 2015 - 8:51am | 232In a report published Wednesday, Oppenheimer analyst Rohit Vanjani discussed a recent investor meeting with OvaScience Inc (NASDAQ: OVAS)'s management team, including the company's Chief Executive Officer Dr. Michelle Dipp. OvaScience noted that both patient and physician inquiries have moved...